Acceleron Pharma (XLRN) PT Raised to $63 at Citi
Tweet
Share
E-mailGet Alerts XLRN Hot Sheet
Price: $178.75 --0%
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Join SI Premium – FREE
Citi raised its price target on Acceleron Pharma (NASDAQ: XLRN) to $63.00 (from $44.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades China Resources Cement Holdings (1313:HK) (CARCY) to Sell
- Yankuang Energy Group (1171:HK) PT Lowered to HK$14 at Goldman Sachs
- Knights Group Holdings plc (KGH:LN) PT Raised to GBP2.50 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
